Stay updated on NC410 Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a new revision (v3.6.4) that supersedes the previous version (v3.6.3), indicating an updated page revision.SummaryDifference0.1%

- Check16 days agoChange DetectedA new version entry on 2026-07-15 adds core study sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and related areas (Oversight, Study Status, Recruitment Status) to the record. The update also introduces a Quality Control status (Has Not Concluded) and navigation items such as More Information and Document Section.SummaryDifference1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2 and signaling an update to the record's documentation.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and an earlier revision (v3.6.0) was removed, updating the list of published versions.SummaryDifference0.1%

- Check45 days agoChange DetectedThe Record History page shows a refreshed UI for the version list and layout, while the underlying history data remains unchanged. This indicates a visual update rather than content changes to the study record.SummaryDifference0.1%

- Check52 days agoChange DetectedThe study's recruitment status is updated to not recruiting, and the record history shows the page has been revised to version 3.6.0.SummaryDifference0.5%

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.